USANA Health Sciences, Inc. (NYSE:USNA) Position Cut by Legal & General Group Plc

Legal & General Group Plc lowered its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 1.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,756 shares of the company’s stock after selling 54 shares during the period. Legal & General Group Plc’s holdings in USANA Health Sciences were worth $217,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of USNA. State Street Corp raised its position in USANA Health Sciences by 104.3% in the fourth quarter. State Street Corp now owns 190,838 shares of the company’s stock valued at $11,676,000 after buying an additional 97,430 shares during the last quarter. Norges Bank acquired a new position in USANA Health Sciences during the fourth quarter valued at $6,855,000. Teachers Advisors LLC increased its position in shares of USANA Health Sciences by 137.7% in the fourth quarter. Teachers Advisors LLC now owns 217,677 shares of the company’s stock worth $13,322,000 after buying an additional 126,090 shares during the period. Quotient Investors LLC purchased a new position in shares of USANA Health Sciences during the first quarter worth approximately $605,000. Finally, Janney Montgomery Scott LLC increased its position in shares of USANA Health Sciences by 37.7% in the first quarter. Janney Montgomery Scott LLC now owns 6,619 shares of the company’s stock worth $381,000 after buying an additional 1,813 shares during the period. 43.90% of the stock is currently owned by hedge funds and other institutional investors.

Shares of USANA Health Sciences, Inc. (USNA) traded up 1.29% on Friday, reaching $58.80. The company’s stock had a trading volume of 120,279 shares. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $150.00. The company has a market cap of $1.44 billion, a P/E ratio of 15.27 and a beta of 1.10. The company has a 50 day moving average price of $61.41 and a 200 day moving average price of $60.57.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by $0.08. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The firm had revenue of $257.10 million during the quarter, compared to analyst estimates of $273.61 million. During the same period in the prior year, the business earned $2.07 EPS. The business’s revenue for the quarter was down .5% compared to the same quarter last year. On average, analysts anticipate that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.

USANA Health Sciences announced that its board has initiated a share repurchase plan on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 46% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: “USANA Health Sciences, Inc. (NYSE:USNA) Position Cut by Legal & General Group Plc” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://stocknewstimes.com/2017/08/12/usana-health-sciences-inc-nyseusna-position-cut-by-legal-general-group-plc.html.

A number of research analysts have commented on the company. BidaskClub downgraded USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st. Pivotal Research upgraded USANA Health Sciences from a “hold” rating to a “buy” rating and boosted their target price for the company from $55.00 to $75.00 in a research note on Wednesday, May 3rd.

In related news, Director Gilbert A. Fuller sold 1,483 shares of USANA Health Sciences stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $57.67, for a total value of $85,524.61. Following the sale, the director now owns 1,483 shares of the company’s stock, valued at $85,524.61. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Paul A. Jones sold 9,851 shares of USANA Health Sciences stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now directly owns 6,020 shares in the company, valued at approximately $388,290. The disclosure for this sale can be found here. Insiders sold a total of 171,334 shares of company stock worth $10,413,675 in the last three months. Company insiders own 53.20% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply